Please login to the form below

Not currently logged in
Email:
Password:

Janssen

This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.

Janssen reports positive real-world data for Tremfya in psoriatic arthritis

Janssen reports positive real-world data for Tremfya in psoriatic arthritis

Janssen Pharmaceuticals, a Johnson &Johnson company, has announced positive real-world data for its IL-23 inhibitor Tremfya (guselkumab) in adults with treatment-resistant active psoriatic arthritis (PsA). ... in pain, physical function and fatigue

Latest news

More from news
Approximately 177 fully matching, plus 427 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 28 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....